The Association for Accessible Medicines has urged a Delaware federal judge to reject part of a magistrate judge's report and recommendation not to dismiss Amarin Pharma Inc.'s infringement suit against Hikma Pharmaceuticals USA Inc. over its heart drug Vascepa, saying that if the suit goes forward, patients will be forced to pay higher prices for branded drugs.
Related Keywords
Delaware , United States , , Amarin Pharma Inc , Association For Accessible Medicines , Hikma Pharmaceuticals United States Inc , Accessible Medicines , Amarin Pharma , Hikma Pharmaceuticals United States ,
comparemela.com © 2020. All Rights Reserved.